NCT05647083

Brief Summary

This research aims to investigate the effect of massage on diabetic foot risk, HbA1c and physiological parameters in individuals with type 2 diabetes. This randomized controlled experimental design will be carried out in Bolu Izzet Baysal State Hospital Köroğlu Unit Internal Medicine Polyclinic and Internal Medicine Service. According to power analysis, the minimum sample size was determined as 60 people, 30 of which were in the intervention group and 30 in the control group. Data collection tools include "Peripheral Neuropathy Sign and Symptom Score", "Ankle-Brachial Index (ABI)", "Glycemic Control Assessment (HbA1c)", "Physiological Parameters (blood pressure, heart rate and oxygen saturation)", "Inlow's 60-second Diabetic Food Screen". A total of 24 massage sessions will be applied to the intervention group, 2 times a week during the 12-week working period. Participants in the control group will continue their medical treatment protocols and massage will not be applied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 12, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2024

Completed
Last Updated

April 19, 2024

Status Verified

April 1, 2024

Enrollment Period

1.4 years

First QC Date

November 21, 2022

Last Update Submit

April 18, 2024

Conditions

Keywords

massageglycemic controldiabetic foot risk

Outcome Measures

Primary Outcomes (8)

  • Means of Peripheral Neuropathy Sign and Symptom Score

    Peripheral neuropathy consists of two parts: symptom and symptom score. For the peripheral neuropathy symptom score; * Discomfort they feel in their feet, * Location of complaints, * The presence of complaints increases at night, * Time of occurrence of complaints and * 5 questions will be asked about how the complaints decreased. Peripheral neuropathy symptom score obtained from 5 questions was 0-2 points, "normal"; 3-4 points, "mild neuropathy"; 5-6 points, "moderate neuropathy"; A score of 7-9 will be considered "severe neuropathy". For peripheral neuropathy finding score; It will be determined based on four parameters including 1. Vibration sense, 2. Pimpiric test, 3. Achille tendon reflex, 4. Protective sensory examination

    Change from baseline Neuropathy score at 3 months

  • Means of Ankle-Brachial Index Score

    It is calculated by dividing the tibialis posterior pressure by the brachial arterial pressure. The highest of the four measurements at the ankles and feet is divided by the two higher brachial measurements. The normal value is close to 1.

    Change from baseline Ankle-Brachial Index score at 3 months

  • Means of HbA1c (%)

    HbA1c values of the participants will be monitored as a glycemic control parameter. The HbA1c value will be evaluated at baseline and 3 months later, as it represents the three-month average blood glucose value. For the measurement of HbA1c, the test results within the last week will be taken from the participants at the beginning and a blood sample will be taken into ethylenediaminetetraacetic acid (EDTA) coated tubes (2 mL whole) by a nurse three months later.

    Change from baseline HbA1c score at 3 months

  • Means of systolic blood pressure (mmHg)

    It will be measured by the researcher with a manual measurement tool.

    Change from baseline systolic blood pressure at 3 months

  • Means of diastolic blood pressure (mmHg)

    It will be measured by the researcher with a manual measurement tool.

    Change from baseline diastolic blood pressure at 3 months

  • Means of heart rate (/minutes)

    It will be measured by the researcher with a pulse oximeter.

    Change from baseline heart rate at 3 months

  • Means of oxygen saturation (%)

    It will be measured by the researcher with a pulse oximeter.

    Change from baseline oxygen saturation at 3 months

  • Means of diabetic foot risk score

    "Inlow's 60-second Diabetic Food Screen" form will be used in diabetes foot risk assessment. Diabetic foot examination consists of 12 parameters. Skin Assessment, Evaluation of Nail Structure, deformity, Evaluation of the Shoe, Heat Evaluation - Being Cold, Heat Evaluation - Being Hot, Range of Motion Evaluation, Sensory Evaluation, Sensory Evaluation (Assessment with questions directed to individuals), Evaluation of Pedal Pulses, Dependent Rubor Evaluation, Evaluation of Erythema (Redness). The minimum score to be taken from the foot examination form is evaluated as 0 and the maximum score as 23 points. The higher the score, the higher the risk of diabetic foot.

    Change from baseline diabetic foot risk score at 3 months

Study Arms (2)

Intervention group

EXPERIMENTAL

A total of 24 massage sessions will be applied to the intervention group, 2 times a week during the 12-week working period. Sesame oil will be used as the main oil in the massage application. Massage times are recommended as 10-15 minutes for upper extremity massage and 15-20 minutes for lower extremity massage.

Other: Massage therapy

Control group

NO INTERVENTION

Participants in the control group will continue their medical treatment protocols and massage will not be applied. Measurement tools and physiological measurements will be evaluated at the frequency specified in the intervention group, using the same measurement tools and the same measurement methods.

Interventions

Classical massage will be applied to the hands and feet, which is expected to take an average of 30 minutes.

Intervention group

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being between 30-75 years old,
  • Diagnosed with diabetes at least 6 months ago,
  • Absence of irritation, ulceration in the areas where the massage will be applied (hands, feet and legs),
  • No problem in verbal communication,
  • Being able to speak Turkish,
  • No diagnosis of psychiatric disease,
  • Absence of amputation in the upper and lower extremities,
  • Having HbA1c test results in the last 1 week,
  • Not having had Covid-19 in the last 6 months
  • No experience of massage application in the last 1 month
  • Willingness to participate in the research

You may not qualify if:

  • Presence of diabetic ulcer and foot wound,
  • Irritation and ulceration in the areas where the massage will be applied (hands, feet and legs),
  • Having problems in verbal communication,
  • Not being able to speak Turkish,
  • Having a diagnosis of psychiatric illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Provincial Health Directorate Bolu Izzet Baysal State Hospital

Bolu, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Peripheral Nervous System Diseases

Interventions

Massage

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Elif Gençer Şendur, MSC

    Abant Izzet Baysal University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 21, 2022

First Posted

December 12, 2022

Study Start

September 9, 2022

Primary Completion

February 9, 2024

Study Completion

February 9, 2024

Last Updated

April 19, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations